Research Report University Hospital clinical trial PH3-01

Abstract

Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer With Low to Intermediate HER2 Expressions With NeuVaxTMTreatment

Keywords

• Breast cancer
• NeuVaxTM